EBS vs EPAM · rev $1.04B vs P/E 14, rev $4.73B
Emergent Biosolutions Inc (EBS) versus EPAM Systems Inc (EPAM) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
EBS currently screens at market cap $416.4M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Not investment advice. Open the EBS and EPAM stock pages for the full models.
Not investment advice.